Ischemia-induced angiogenesis is impaired in aminopeptidase A deficient mice via down-regulation of HIF-1α

Biochemical and Biophysical Research Communications

Volumn 402, Issue 2, 2010, Pages 396-401

  Kubota, Ryuji ^a   Numaguchi, Yasushi ^a   Ishii, Masakazu ^a   Niwa, Manabu ^a   Okumura, Kenji ^a   Naruse, Keiji ^b   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Aminopeptidase A; Angiogenesis; Angiotensin; HIF 1 ; Ischemia

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GLUTAMYL AMINOPEPTIDASE; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEASOME;

ANGIOGENESIS; ANIMAL EXPERIMENT; AORTA; ARTICLE; CAPILLARY DENSITY; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HINDLIMB; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; LEG ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN STABILITY; STEM CELL; UBIQUITINATION; WESTERN BLOTTING;

ANIMALS; CELL HYPOXIA; DOWN-REGULATION; GLUTAMYL AMINOPEPTIDASE; HINDLIMB; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC;

MUS;

EID: 78149464801     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.043     Document Type: Article

References (27)

1. Zini S., Fournie-Zaluski M.C., Chauvel E., Roques B.P., Corvol P, Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. USA 1996, 93:11968-11973.
2. Bodineau L., Frugière A., Marc Y., Inguimbert N., Fassot C., Balavoine F., et al. Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Hypertension 2008, 51:1318-1325.
3. Goto Y., Hattori A., Ishii Y., Mizutani S., Tsujimoto M. Enzymatic properties of human aminopeptidase A. Regulation of its enzymatic activity by calcium and angiotensin IV. J. Biol. Chem. 2006, 281:23503-23513.
4. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
5. Watanabe T., Barker T.A., Berk B.C. Angiotensin II and the endothelium: diverse signals and effects. Hypertension 2005, 45:163-169.
6. Marchiò S., Lahdenranta J., Schlingemann R.O., Valdembri D., Wesseling P., Arap M.A., et al. Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 2004, 5:151-162.
7. Lin Q., Taniuchi I., Kitamura D., Wang J., Kearney J.F., Watanabe T., et al. T and B cell development in BP-1/6C3/aminopeptidase A-deficient mice. J. Immunol. 1998, 160:4681-4687.
8. Mitsui T., Nomura S., Okada M., Ohno Y., Kobayashi H., Nakashima Y., et al. Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice. Mol. Med. 2003, 9:57-62.
9. Mizutani S., Ishii M., Hattori A., Nomura S., Numaguchi Y., Tsujimoto M., et al. New insights into the importance of aminopeptidase A in hypertension. Heart Fail Rev. 2008, 13:273-284.
10. Ishii M., Numaguchi Y., Okumura K., Kubota R., Ma X., Murakami R., et al. Mesenchymal stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia. Atherosclerosis 2009, 206:109-118.
11. Numaguchi Y., Ishii M., Kubota R., Morita Y., Yamamoto K., Matsushita T., et al. Ablation of angiotensin IV receptor attenuates hypofibrinolysis via PAI-1 downregulation and reduces occlusive arterial thrombosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2102-2108.
12. Kobayashi M., Inoue K., Warabi E., Minami T., Kodama T. A simple method of isolating mouse aortic endothelial cells. J. Atheroscler. Thromb. 2005, 12:138-142.
13. Iwase T., Nagaya N., Fujii T., Itoh T., Murakami S., Matsumoto T., et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc. Res. 2005, 66:543-551.
14. Calvani M., Rapisarda A., Uranchimeg B., Shoemaker R.H., Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 2006, 107:2705-2712.
15. Ishii M., Hattori A., Numaguchi Y., Tsujimoto M., Ishiura S., Kobayashi H., et al. The effect of recombinant aminopeptidase A on hypertension in spontaneously hypertensive rats: its effect in comparison with candesartan. Horm Metab. Res. 2008, 40:887-891.
16. Numaguchi Y., Naruse K., Harada M., Osanai H., Mokuno S., Murase K., et al. Prostacyclin synthase gene transfer accelerates reendothelialization and inhibits neointimal formation in rat carotid arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 1999, 19:727-733.
17. Shimada T., Takeshita Y., Murohara T., Sasaki K., Egami K., Shintani S., et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004, 110:1148-1155.
18. Ishii M., Koike C., Igarashi A., Yamanaka K., Pan H., Higashi Y., et al. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem. Biophys. Res. Commun. 2005, 332:297-303.
19. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., Isner J.M. Mouse model of angiogenesis. Am. J. Pathol. 1998, 152:1667-1679.
20. Inoue N., Kondo T., Kobayashi K., Aoki M., Numaguchi Y., Shibuya M., et al. Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes. Arterioscler. Thromb. Vasc. Biol. 2007, 27:99-105.
21. Rey S., Semenza G.L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc. Res. 2010, 86:236-242.
22. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., et al. Cell proliferation and tumour angiogenesis. Nature 1998, 394:485-490.
23. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 2003, 9:677-684.
24. Tang N., Wang L., Esko J., Giordano F.J., Huang Y., Gerber H.P., et al. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004, 6:85-495.
25. Varshavsky A. The N-end rule. Cell 1992, 69:725-735.
26. Mogk A., Schmidt R., Bukau B. The N-end rule pathway for regulated proteolysis: prokaryotic and eukaryotic strategies. Trends Cell Biol. 2007, 17:165-172.
27. Sevalle J., Amoyel A., Robert P., Fournié-Zaluski M.C., Roques B., Checler F. Aminopeptidase A contributes to the N-terminal truncation of amyloid beta-peptide. J. Neurochem. 2009, 109:248-256.